Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer

被引:20
作者
Axelsson, C. K. [1 ]
Duering, M. [2 ]
Christiansen, P. M. [3 ]
Wamberg, P. A. [4 ]
Soe, K. L. [5 ]
Moller, S. [2 ]
机构
[1] Herlev Univ Hosp, Dept F Breast Surg, Copenhagen, Denmark
[2] Rigshosp, DBCG Secretariat, DK-2100 Copenhagen, Denmark
[3] Aarhus Univ Hosp, Surg Dept P, DK-8000 Aarhus, Denmark
[4] Vejle Hosp, Surg Dept K, Vejle, Denmark
[5] Odense Univ Hosp, Surg Dept A, DK-5000 Odense, Denmark
关键词
SENTINEL-LYMPH-NODE; PROGNOSTIC-SIGNIFICANCE; NUMBER; DISSECTION; MANAGEMENT; CARCINOMA; BIOPSY;
D O I
10.1002/bjs.6350
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
Background: This study examined whether axillary lymph node dissection (ALND) with removal of many normal lymph nodes resulted in a reduced rate of axillary recurrence and better survival, as reported in recent studies. Methods: The follow-up analyses were based on 8657 patients with node-negative primary breast cancer treated solely by surgery. Median follow-up was 9 years. Results: The number of lymph nodes removed correlated with a reduction in the rate of subsequent axillary recurrence (from 2.1 to 0.4 per cent; P = 0.037), local recurrence (from 7.4 to 3.8 per cent; P < 0.001) distant metastases (from 15.0 to 10.3 per cent; P < 0.001) and death as first event (from 7.5 to 5.5 per cent; P = 0.012). Conclusion: When ALND) is indicated, at least ten axillary lymph nodes should be retrieved. The role of ALND as primary treatment has decreased significantly during the past decade. The findings leave the concept of the sentinel node biopsy intact, as a highly specific procedure compared to ALND.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 28 条
[1]
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]
Axillary staging during surgery for breast cancer [J].
Axelsson, C. K. ;
Mouridsen, H. T. ;
Duering, M. ;
Moller, S. .
BRITISH JOURNAL OF SURGERY, 2007, 94 (03) :304-309
[3]
Axelsson CK, 2000, ACTA ONCOL, V39, P283
[4]
AXILLARY DISSECTION OF LEVEL-I AND LEVEL-II LYMPH-NODES IS IMPORTANT IN BREAST-CANCER CLASSIFICATION [J].
AXELSSON, CK ;
MOURIDSEN, HT ;
ZEDELER, K .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) :1415-1418
[5]
The genomic heritage of lymph node metastases: Implications for clinical management of patients with breast cancer [J].
Becker, Tyson E. ;
Ellsworth, Rachel E. ;
Deyarmin, Brenda ;
Patney, Heather L. ;
Jordan, Rick M. ;
Hooke, Jeffrey A. ;
Shriver, Craig D. ;
Ellsworth, Darrell L. .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (04) :1056-1063
[6]
Management of the axilla in women with breast cancer [J].
Benson, John R. ;
della Rovere, G. Querci .
LANCET ONCOLOGY, 2007, 8 (04) :331-348
[7]
Tumour dormancy in breast cancer: an update [J].
Brackstone, Muriel ;
Townson, Jason L. ;
Chambers, Ann F. .
BREAST CANCER RESEARCH, 2007, 9 (03)
[8]
Camp RL, 2000, CANCER, V88, P108, DOI 10.1002/(SICI)1097-0142(20000101)88:1<108::AID-CNCR15>3.0.CO
[9]
2-B
[10]
Recurrence pattern and prognosis in low-risk breast cancer patients - Data from the DBCG 89-A programme [J].
Christiansen, Peer ;
Bjerre, Karsten ;
Al-Suliman, Nidal ;
Moller, Susanne .
ACTA ONCOLOGICA, 2008, 47 (04) :691-703